Moore Capital Management, LP Poly Pid Ltd. Transaction History

Moore Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$3.92 - $6.25 $490,795 - $782,518	-125,203 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.52 - $8.42 $854,159 - $1.3 Million	-154,739 Reduced 55.28%	125,203 $719,000
Q3 2021 Nov 15, 2021	SELL	$7.05 - $9.48 $14,346 - $19,291	-2,035 Reduced 0.72%	279,942 $2.18 Million
Q2 2021 Aug 16, 2021	SELL	$8.4 - $9.99 $12,146 - $14,445	-1,446 Reduced 0.51%	281,977 $2.55 Million
Q1 2021 May 17, 2021	BUY	$8.92 - $15.5 $56,668 - $98,471	6,353 Added 2.29%	283,423 $2.6 Million
Q4 2020 Feb 16, 2021	BUY	$8.89 - $13.5 $595,221 - $903,879	66,954 Added 31.87%	277,070 $2.76 Million
Q3 2020 Nov 16, 2020	BUY	$11.0 - $17.33 $54,615 - $86,043	4,965 Added 2.42%	210,116 $2.31 Million
Q2 2020 Aug 14, 2020	BUY	$18.03 - $19.0 $3.7 Million - $3.9 Million	205,151 New	205,151 $3.7 Million

Ticker PYPD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,551,200
Market Cap $64.5M
Description
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.